Rhythm Pharmaceuticals Inc (NASDAQ:RYTM): Samuel Isaly’s OrbiMed Advisors filed an amended 13D.
You can check out OrbiMed Advisors’ latest holdings and filings here.
Please follow OrbiMed Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about OrbiMed Advisors or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|OrbiMed Advisors||0||2,901,295||0||2,901,295||2,901,295||10.7 %|
|OrbiMed Capital GP V||0||2,901,295||0||2,901,295||2,901,295||10.7 %|
|Samuel D. Isaly||0||2,901,295||0||2,901,295||2,901,295||10.7 %|
Page 1 of 14 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
RHYTHM PHARMACEUTICALS, INC.
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Samuel D. Isaly
601 Lexington Avenue, 54th Floor
New York, NY 10022
Telephone: (212) 739-6400
Authorized to Receive Notices and Communications)
October 10, 2017